Rational design and synthesis of topoisomerase I and II inhibitors based on oleanolic acid moiety for new anti-cancer drugs.

[1]  J. Berger,et al.  Structure and mechanism of DNA topoisomerase II , 1996, Nature.

[2]  R. Ballini,et al.  Synthesis of (Z)-9,10-Epoxynonacosane, a Long-Chain Epoxide Isolated from Stem Wax of Rubus thibetanus , 1997 .

[3]  W. Reynolds,et al.  Assignment of 1H and 13C spectra and investigation of hindered side‐chain rotation in lupeol derivatives † , 2000 .

[4]  J. Slupsky,et al.  Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and IIalpha. , 2000, Molecular pharmacology.

[5]  JAMES C. Wang,et al.  Cellular roles of DNA topoisomerases: a molecular perspective , 2002, Nature Reviews Molecular Cell Biology.

[6]  Jinn-Moon Yang,et al.  GEMDOCK: A generic evolutionary method for molecular docking , 2004, Proteins.

[7]  T. Kataoka,et al.  Three new triterpenes from Nerium oleander and biological activity of the isolated compounds. , 2005, Journal of natural products.

[8]  Y. Pommier,et al.  Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex. , 2005, Journal of medicinal chemistry.

[9]  P. Forterre,et al.  Origin and evolution of DNA topoisomerases. , 2007, Biochimie.

[10]  S. Velu,et al.  Analogs of the marine alkaloid makaluvamines: synthesis, topoisomerase II inhibition, and anticancer activity. , 2007, Bioorganic & medicinal chemistry letters.

[11]  Yukishige Ito,et al.  Facile preparation of N-acylsulfonamides by using sulfonyl isocyanate , 2007 .

[12]  M. Merlani,et al.  Synthesis and antituberculosis activity of certain steroidal derivatives of the 5α-series , 2008, Chemistry of Natural Compounds.

[13]  P. Sylvester,et al.  Semisynthetic and biotransformation studies of (1S,2E,4S,6R,7E,11E)-2,7,11-cembratriene-4,6-diol. , 2008, Journal of natural products.

[14]  N. Osheroff,et al.  The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing , 2008, Nucleic acids research.

[15]  P. Sylvester,et al.  Rational design and semisynthesis of betulinic acid analogues as potent topoisomerase inhibitors. , 2009, Journal of natural products.

[16]  F. Da Settimo,et al.  Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs. , 2010, Current medicinal chemistry.

[17]  Y. Pommier.  Drugging topoisomerases: lessons and challenges. , 2013, ACS chemical biology.